Advertisement

Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 3053 | Ordered by Date (descending)
1 2 3 ... 29 30 31  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Curetis–Goetzpartners: investor conference, 201806 supply service Curetis presents at Goetzpartners Healhlcare Day 2018 in London 2018-06-22
Curetis–Informa: investor conference, 201805 supply service Curetis presents at BioEquity Europe 2018 in Ghent 2018-05-14
Curetis–Van Lanschot: investor conference, 201804 supply service Curetis presents at Kempen Life Sciences Conference 2018 in Amsterdam 2018-04-18
Allecra Therapeutics–HC Wainwright: investor conference, 201804 supply service Allecra presents at HC Wainwright Global Life Sciences Conference 2018-04-08
Curetis–HC Wainwright: investor conference, 201804 supply service Curetis presents at HC Wainwright Global Life Sciences Conference in Monte Carlo 2018-04-08
Brainomix–Boehringer: investment, 201804 financing round totalling £7m incl new + co-investor BIVF 2018-04-03
Brainomix–SEVERAL: investment, 201804 financing round £7m led by Parkwalk Advisors + incl BIVF + Chimera Partners + Oxford Univ 2018-04-03
Arsanis–Needham: investor conference, 201803 supply service Arsanis presents at Annual Needham Healthcare Conference in NY 2018-03-27
Medigene–Needham: investor conference, 201803 supply service Medigene presents at Annual Needham Healthcare Conference in NY 2018-03-27
Novartis–GSK: investment, 201803– acquisition $13b of 36.5% stake of Novartis in OTC joint venture giving GSK 100% ownership 2018-03-27
PITBUL project–EU (govt): grant, 201803–2020 Horizon 2020 grant €3.8m to develop ultrafast PoC tuberculosis diagnostic platform 2018-03-24
MorphoSys–SEVERAL: investment, 201803– filing of Form F-1 for proposed ADSs offering + listing at Nasdaq Global Market 2018-03-22
Aton–Grifols: investment, 201803– acquisition 100% of Haema for €220 on a debt free basis by Grifols from Aton GmbH 2018-03-20
Novartis–Harvard Univ: drug delivery technology, 201803– collab develop biomaterial systems for delivery of cancer immuntherapies NIBR + Wyss + Dana 2018-03-20
Robert Bosch Hospital–bio.logis: genetic software, 201803– supply implementation of bio.logis GIMS IT platform at RBK 2018-03-20
Bruker Corp–KAUST: magnet resonance technology, 201803– collab establ KAUST-Bruker Center of Excellence in Magnetic Resonance 2018-03-18
KAUST–Bruker Corp: magnetic resonance technology, 201803 supply 500 MHz super wide-bore MRI spectrometer at KAUST-Bruker CoE in Magnetic Resonance 2018-03-18
KAUST–Bruker Corp: magnetic resonance technology, 201803 supply 900 MHz wide-bore NMR spectrometer at KAUST-Bruker CoE in Magnetic Resonance 2018-03-18
KAUST–Bruker Corp: magnetic resonance technology, 201803 supply 950 MHz NMR spectrometer at KAUST-Bruker CoE in Magnetic Resonance 2018-03-18
KAUST–Bruker Corp: magnetic resonance technology, 201803 supply DNP NMR spectrometer at KAUST-Bruker CoE in Magnetic Resonance 2018-03-18
Biocatalysts Ltd–BRAIN: investment, 201803 acquisition of majority stake in Biocatalysts Ltd by BRAIN AG 2018-03-17
Mérieux–Sartorius: bioreactors, 201803 supply of single-use viral vector manufacturing package to ABL Europe in Strasboug by SSB 2018-03-16
Prexton Therapeutics–Lundbeck: investment, 201803– acquisition €100m upfront + €805m developm + sales milestones ANNOUNCED 2018-03-16
Siemens–SEVERAL: investment, 201803 IPO €4.2b of Siemens Healthineers AG at FSE floating 150m (15% of) shares at €28/share 2018-03-16
Pieris–Cowen: investor conference, 201803 supply service Pieris presents at Cowen & Co Annual Health Care Conference 2018 2018-03-13
Pieris–Oppenheimer: investor conference, 201803 supply service Pieris presents at Oppenheimer Annual Healthcare Conference in NYC 2018-03-13
Arsanis–Cowen: investor conference, 201803 supply service Arsanis presents at Cowen & Co Annual Health Care Conference 2018 2018-03-12
Danaher–KAUST: microscopy, 201803– collab establ KAUST-Leica Center of Excellence in Optical Microscopy 2018-03-12
KAUST–Danaher: microscopy, 201803 supply SP8 confocal platform to new KAUST-Leica Center of Excellence in Optical Microscopy 2018-03-12
Medical Univ Vienna–bio.logis: genetic software, 201803 collab use of bio.logis GIMS.DRM with safety code card at MUW 2018-03-12
Medigene–Informa: partnering conference, 201803 supply service Medigene participates in BIO-Europe Spring 2018 2018-03-12
Medigene–Roth Capital Partners: investor conference, 201803 supply service Medigene presents at Annual Roth Conference 2018 2018-03-11
Novartis–Science 37: clinical research, 201803– collab 3y expansion up to 10 decentralised clinical trials 2018-03-07
Ventech–SEVERAL: investment, 201803 first closing €140m of Ventech Capital V fund with €200m target size 2018-03-07
Magenta Therapeutics–Heidelberg Pharma: antibody-drug conjugates, 201803– collab developm of ADCs for bone marrow transplant using ATAC platform 2018-03-05
Affiris–PR&D: public relations, 201803 service existent by PR&D – Public Relations for Research & Education 2018-03-01
Heidelberg Pharma–MC Services: public relations, 201803 service existent by MC Services 2018-03-01
Heidelberg Pharma–Univ Texas: personalised medicine, 201803– license for Dx + Tx of cancer patients w RNA polymerase II deletion 2018-03-01
Berlin Cures–Russo Partners: public relations, 201802 service existent by Russo Partners 2018-02-26
Bruker Corp–Evosep: liquid chromatography, –201802 collab product integration of timsTOF Pro MS + Evosep One LC for HT clinical proteomics 2018-02-26
Xencor–JSR Corp: cell line development, 201802– four commercial licenses to use Selexis’ SUREtechnology for developm of bispecific antibodies 2018-02-26
IRM² Infrarot Mikroskopie und Messtechnik GmbH–Bruker Corp: investment, 201802 acquisition €na of IRM² by Bruker 2018-02-22
Pieris–RBC Capital Markets: investor conference, 201802 supply service Pieris presents at RBC Capital Markets Global Healthcare Conference 2018-02-22
Cullinan Oncology–MAB Discovery: antibody cancer drug, 201802– collab developm of MAbs based on MAB Discovery’s discovery platform 2018-02-20
Gain Therapeutics–SEVERAL: investment, 201802 investment spin-off of Minorix’ SEE-Tx platform as Gain Therapeutics with Swiss investors + TiVenture 2018-02-20
ABAC Therapeutics–SEVERAL: investment, 201802 financing round Series A €16m led by Pontifax + incl GHSF + Caixa Capital Risc + Debiopharm + Ferrer 2018-02-15
Addex–SEVERAL: investment, 201802–201803 private placement CHF40m with 12.78m new shares at CHF3.13/share plus 0.4 warrants at CHF3.43 2018-02-15
Flatiron Health–Roche: investment, 201802– acquisition $1.9b of remaining 87.4% not already owned by Roche 2018-02-15
Mologen–SEVERAL: investment, 201802–20103 capital increase €4.99m with 2.36m new shares at €2.12/share to existing + new investors 2018-02-15
Bruker Corp–Leerink: investor conference, 201802 supply service Bruker to present at Leerink Partners Global Healthcare Conference 2018 2018-02-14
Hookipa Biotech–Leerink: investor conference, 201802 supply service Hookipa to attend Leerink Partners Global Healthcare Conference 2018 2018-02-14
InflaRx–Leerink: investor conference, 201802 supply service InflaRx presents at Leerink Partners Global Healthcare Conference 2018 2018-02-14
Pieris–SEVERAL: investment, 201802 public offering $50.6m with 5.5m+825k common shares at $8/share 2018-02-13
Swiss Medical Imaging Investment–RAD-x: investment, 201802 acquisition of SMII by RAD-x 2018-02-13
Affimed–SEVERAL: investment, 201802 public offering $26.5m ($24.5m net) with 12.5m+1.725m common shares at $2/share 2018-02-12
Lonza–Kirkstall: cell culture system, 201802– collab ww marketing + distribution of Quasi Vivo System by Lonza 2018-02-12
Pieris–Trophic Communications: public relations, 201802 service existent media relations by Trophic 2018-02-09
Seattle Genetics–Pieris: cancer immunotherapy, 201802– collab $30m upfront + $1.2b milestones + royalties developm antibody-anticalin fusion proteins 2018-02-09
Pfizer–Genedata: bioinformatics, 201802– supply license for Genedata Bioprocess enterprise platform to Pfizer Inc 2018-02-08
Thermo Fisher–Endress+Hauser: lab automation, 201802 collab product integration of AJ’s CyBio FeliX system in cell-free DNA extraction device 2018-02-07
4SC–Life Sciences Partners: investor conference, 201802 supply service 4SC AG presents at BioCapital Europe 2018 2018-02-06
Medigene–Life Sciences Partners: investor conference, 201802 supply service Medigene AG presents at BioCapital Europe 2018 2018-02-06
Servier–ImmunoQure: therapeutic antibodies, 201802– collab developm of INF-alpha human autoantibody for autoimmune diseases 2018-02-06
Faron Pharmaceuticals–Lyomark Pharma: Traumakine, 201802– supply contract manfucturing by Lyocontract GmbH 2018-02-05
Faron Pharmaceuticals–Rentschler: Traumakine, 201802 supply existent contract manfucturing by Rentschler Biopharma SE 2018-02-05
TraitGenetics–SGS: investment, 201802 acquisition of TraitGenetics GmbH by SGS 2018-02-02
Cytosurge–Lab Automation Network: cell analysis technology, 201802– collab product integration to offer automated single-cell biology applications 2018-02-01
Silvacx–Merck (DE): nanoparticle technology, 201802– license excl to Silvacx delivery technology for cancer immunotherapy 2018-02-01
Silvacx–North Rhine-Westphalia (govt): grant, 201802– r+d grant €1.93m 3 years to develop Silvacx technology 2018-02-01
Biotest–Credit Suisse: financial services, 201704 supply service financial advisor with regard to sale of Biotest AG to Ceat Group (CN) 2018-01-31
Immunicum–Trophic Communications: public relations, 201801 service existent IR + media relations EU + US by Trophic 2018-01-31
STAT-Diagnostica–Qiagen: investment, 201801– acquisition $147m upfront cash + $44m milestones of STAT-Dx by Qiagen ANNOUNCED 2018-01-31
eTherapists–Creathor Venture: investment, 201801 financing round 7-digit € for Humanoo.com from Creathor + DvH Ventures et al 2018-01-30
eTherapists–SEVERAL: investment, 201801 financing round 7-digit € for Humanoo.com from Creathor + DvH Ventures et al 2018-01-30
Helsinn–Scientific Centre of Monaco: cancer drug, 201801– collab research new pharmacological inhibitors for clear cell renal cell carcinoma 2018-01-30
Ablynx–Sanofi: investment, 201801– acquisition recommended cash tender offer €3.9b with €45/share 2018-01-29
Clariant–SABIC: investment, 201801 acquisition 24.99% shareholding by SABIC via acquisition of shares previously held by White Tale + 40 North 2018-01-25
Topas Therapeutics–Univ Hamburg: anti-inflammatory drugs, 201801– collab Topas excl translational partner for liver inflammation CRC at UKE 2018-01-25
ImmuPharma–SEVERAL: investment, 201801 placing £10m of 6.945m new ordinary shares at 144p/share 2018-01-24
Nebion–Qlucore: genomic software tools, 201801– collab integration of Qlucore Omics Explorer s/w + Genevestigator s/w for gene expression analysis 2018-01-24
Novartis–Spark Therapeutics: voretigene neparvovec-rzyl, 201801– license ww outside US to develop + register + commerc gene therapy Luxtarna 2018-01-24
High-Tech Gründerfonds–Dräger: investment, 201801 investment of Dräger in HTGF III Fund 2018-01-23
Juno Therapeutics–Celgene: investment, 201801– cash tender offer $9b net of cash/securities + shares already owned by Celgene $87/share 2018-01-22
Novartis–Biocon: biosimilars, 201801– collab strategic ww excl developm + production + comercialisation Sandoz + Biocon 2018-01-18
Eximmium–Helmholtz: investment, 201801 seed funding €250k from Helmholtz Enterprise + Helmholtz Zentrum München at spin off of Eximmium 2018-01-17
Sartorius–Synpromics: genomic technology, 201801 collab existent with Sartorius Stedim Cellca 2018-01-17
Owkin–SEVERAL: investment, 201801 financing round Series A $11m led by Otium Venture + incl Cathay Innovation + Plug and Play + NJF Capital 2018-01-16
Intelligent Pharma–Mind the Byte: investment, 201801 acquisition €na 100% of Intelligent Pharma by Mind the Byte 2018-01-11
Mind the Byte–SEVERAL: investment, 201801– financing round €3m (1/3 of company) to finance acquisition of Intelligent Pharma PLANNED 2018-01-11
Structural Genomics Consortium–Enamine: chemical compound libraries, 201801– supply new generation of Diamond-SGC-iNEXT (DSI) Poised Library 2018-01-10
BeiGene–Boehringer: biopharmaceuticals, 201801– supply manufacturing of tislelizumab by Boehringer in Shanghai 2018-01-09
BioNTech–Scancell: cancer immunotherapy, 201801– collab research using Moditope platform w excl license option for BioNTech 2018-01-09
Thermo Fisher–JPMorgan Chase: investor conference, 201801 supply service Thermo Fisher presents at JP Morgan Healthcare Conference 2018 2018-01-09
Bruker Corp–JPMorgan Chase: investor conference, 201801 supply service Bruker presents at JP Morgan Healthcare Conference 2018 2018-01-08
CureVac–JPMorgan Chase: investor conference, 201801 supply service CureVac presents at JP Morgan Healthcare Conference 2018 2018-01-08
General Electric–Roche: diagnostics, 201801– collab developm integrated digital + IVD + in vivo diagnostics platform for oncology + critical care 2018-01-08
Hookipa Biotech–JPMorgan Chase: investor conference, 201801 supply service Hookipa presents at JP Morgan Healthcare Conference 2018 2018-01-08
Indivumed–EU (govt): credit, 201801– EIB/EFSI grant €40m to create Global Cancer Database Solution 2018-01-08
InflaRx–JPMorgan Chase: investor conference, 201801 supply service InflaRx presents at JP Morgan Healthcare Conference 2018 2018-01-08
TiGenix–Takeda: investment, 201801– aquisition public cash takeover offer €520m for remaining 95.8% for €1.78/share ANNOUNCED 2018-01-05
1 2 3 ... 29 30 31  next pagenext page



Advertisement

Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px Picture EBD Group ChinaBio Partnering Forum 2018 Suzhou CBPF April 120x180px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 120x240px Picture EBD Group ChinaBio Partnering Forum 2018 Suzhou CBPF April 120x180px